Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA. / Bozkurt, Murat Fani; Virgolini, Irene; Balogova, Sona; Beheshti, Mohsen; Rubello, Domenico; Decristoforo, Clemens; Ambrosini, Valentina; Kjaer, Andreas; Delgado-Bolton, Roberto; Kunikowska, Jolanta; Oyen, Wim J G; Chiti, Arturo; Giammarile, Francesco; Fanti, Stefano.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, No. 9, 08.2017, p. 1588-1601.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Bozkurt, MF, Virgolini, I, Balogova, S, Beheshti, M, Rubello, D, Decristoforo, C, Ambrosini, V, Kjaer, A, Delgado-Bolton, R, Kunikowska, J, Oyen, WJG, Chiti, A, Giammarile, F & Fanti, S 2017, 'Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA', European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, no. 9, pp. 1588-1601. https://doi.org/10.1007/s00259-017-3728-y

APA

Bozkurt, M. F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., Ambrosini, V., Kjaer, A., Delgado-Bolton, R., Kunikowska, J., Oyen, W. J. G., Chiti, A., Giammarile, F., & Fanti, S. (2017). Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA. European Journal of Nuclear Medicine and Molecular Imaging, 44(9), 1588-1601. https://doi.org/10.1007/s00259-017-3728-y

Vancouver

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C et al. Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA. European Journal of Nuclear Medicine and Molecular Imaging. 2017 Aug;44(9):1588-1601. https://doi.org/10.1007/s00259-017-3728-y

Author

Bozkurt, Murat Fani ; Virgolini, Irene ; Balogova, Sona ; Beheshti, Mohsen ; Rubello, Domenico ; Decristoforo, Clemens ; Ambrosini, Valentina ; Kjaer, Andreas ; Delgado-Bolton, Roberto ; Kunikowska, Jolanta ; Oyen, Wim J G ; Chiti, Arturo ; Giammarile, Francesco ; Fanti, Stefano. / Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA. In: European Journal of Nuclear Medicine and Molecular Imaging. 2017 ; Vol. 44, No. 9. pp. 1588-1601.

Bibtex

@article{ad5d6773902847e6862239b09cecdf67,
title = "Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA",
abstract = "PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.",
keywords = "Dihydroxyphenylalanine/analogs & derivatives, Gallium Radioisotopes, Heterocyclic Compounds, 1-Ring/chemistry, Humans, Image Interpretation, Computer-Assisted, Neuroendocrine Tumors/diagnostic imaging, Peptides/chemistry, Positron Emission Tomography Computed Tomography/methods, Practice Guidelines as Topic, Quality Control, Receptors, Somatostatin/metabolism, Tissue Distribution",
author = "Bozkurt, {Murat Fani} and Irene Virgolini and Sona Balogova and Mohsen Beheshti and Domenico Rubello and Clemens Decristoforo and Valentina Ambrosini and Andreas Kjaer and Roberto Delgado-Bolton and Jolanta Kunikowska and Oyen, {Wim J G} and Arturo Chiti and Francesco Giammarile and Stefano Fanti",
year = "2017",
month = aug,
doi = "10.1007/s00259-017-3728-y",
language = "English",
volume = "44",
pages = "1588--1601",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer",
number = "9",

}

RIS

TY - JOUR

T1 - Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA

AU - Bozkurt, Murat Fani

AU - Virgolini, Irene

AU - Balogova, Sona

AU - Beheshti, Mohsen

AU - Rubello, Domenico

AU - Decristoforo, Clemens

AU - Ambrosini, Valentina

AU - Kjaer, Andreas

AU - Delgado-Bolton, Roberto

AU - Kunikowska, Jolanta

AU - Oyen, Wim J G

AU - Chiti, Arturo

AU - Giammarile, Francesco

AU - Fanti, Stefano

PY - 2017/8

Y1 - 2017/8

N2 - PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.

AB - PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.

KW - Dihydroxyphenylalanine/analogs & derivatives

KW - Gallium Radioisotopes

KW - Heterocyclic Compounds, 1-Ring/chemistry

KW - Humans

KW - Image Interpretation, Computer-Assisted

KW - Neuroendocrine Tumors/diagnostic imaging

KW - Peptides/chemistry

KW - Positron Emission Tomography Computed Tomography/methods

KW - Practice Guidelines as Topic

KW - Quality Control

KW - Receptors, Somatostatin/metabolism

KW - Tissue Distribution

UR - https://link.springer.com/article/10.1007%2Fs00259-017-3807-0

U2 - 10.1007/s00259-017-3728-y

DO - 10.1007/s00259-017-3728-y

M3 - Journal article

C2 - 28547177

VL - 44

SP - 1588

EP - 1601

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 9

ER -

ID: 194527303